Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Astrana Health Community
NasdaqCM:ASTH Community
3
Narratives
written by author
0
Comments
on narratives written by author
10
Fair Values set
on narratives written by author
Community Investing Ideas
Astrana Health
Popular
Undervalued
Overvalued
Astrana Health
AN
AnalystLowTarget
Consensus Narrative from 9 Analysts
Policy And Integration Risks Will Hamper Prospects But Enable Recovery
Key Takeaways Heavy reliance on government healthcare programs and evolving policy changes introduces considerable uncertainty and risk to Astrana Health's earnings and revenue outlook. Expansion through acquisitions and investment in technology may strain operational efficiency and margins if integration and innovation fail to keep up with industry demands.
View narrative
US$35.00
FV
16.2% undervalued
intrinsic discount
22.81%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Astrana Health
AN
AnalystHighTarget
Consensus Narrative from 9 Analysts
Aging US Population And Medicare Advantage Will Transform Care Delivery
Key Takeaways Astrana's scalable care model, tech integration, and risk arrangements enable superior margin expansion, efficiency, and stable earnings compared to peers. Strong Medicare Advantage positioning, disciplined M&A, and industry consolidation drive outperformance in enrollment and long-term growth opportunities.
View narrative
US$54.00
FV
45.7% undervalued
intrinsic discount
28.83%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
2 days ago
author updated this narrative
Astrana Health
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
Value Based Care And Data Integration Will Advance US Healthcare
Key Takeaways Transition to value-based care contracts and strategic acquisitions are driving higher-quality revenue, improved retention, and positioning the company for sustainable growth. Investments in proprietary technology and operational integration support better cost control, margin expansion, and increased competitiveness in a changing healthcare landscape.
View narrative
US$43.89
FV
33.2% undervalued
intrinsic discount
23.26%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
4 days ago
author updated this narrative
Your Valuation for
ASTH
ASTH
Astrana Health
Your Fair Value
US$
Current Price
US$29.33
31.9% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
5b
2015
2018
2021
2024
2025
2027
2030
Revenue US$5.3b
Earnings US$55.8m
Advanced
Set Fair Value